Table 1 Baseline characters of patients
Variables | HBV (n = 102) | IPH (n = 86) |
|---|---|---|
Age (year) | 50.3 ± 11.1 | 47.5 ± 12.2 |
No. of male | 68 (66.7%) | 45 (52.3%) |
GEV | ||
Non-HRV | 55 (53.9%) | 56 (65.1%) |
HRV | 47 (46.1%) | 30 (34.9%) |
2D-SWE (kPa) | ||
LS | 16.2 ± 4.3 | 9.4 ± 2.4 |
SS | 35.5 ± 9.8 | 39.3 ± 9.9 |
Conventional US | ||
Spleen size (cm) | ||
Thickness | 4.9 ± 1.0 | 5.0 ± 0.7 |
Diameters | 17.0 ± 4.4 | 15.9 ± 3.4 |
PVF (ml/min) | 1882.0 (1424.3–2897.0) | 2008.0 (1171.0–2898.0) |
SVF (ml/min) | 1022.0 (626.0–2129.5) | 1213.0 (672.0–1763.0) |
Laboratory values | ||
ALT (IU/L) | 24.5 (17.8–34.0) | 19.0 (13.0–24.0) |
ALB(g/L) | 35.9 (31.9–40.6) | 39.1 (33.5–43.2) |
AST(IU/L) | 31.0 (22.0–37.5) | 23.0 (19.0–28.0) |
TBIL (µmol/L) | 20.2 (13.6–31.3) | 17.7 (13.3–22.2) |
DBIL (µmol/L) | 10.3 (7.0–15.5) | 7.2 (5.7–8.8) |
IBIL (µmol/L) | 10.2 (6.5–17.1) | 10.9 (7.5–14.3) |
ALP(IU/L) | 80.0 (60.3–102.0) | 74.0 (56.0–110.0) |
GGT(IU/L) | 39.0 (22.0–61.8) | 30.0 (22.0–51.0) |
PLT (109/µl) | 49.0 (32.8–76.8) | 62.0 (41.0–81.0) |
PT(s) | 16.9 (15.8–18.4) | 14.8 (12.9–15.2) |